Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of GBP 1.08 billion. The enterprise value is 1.37 billion.

Market Cap	1.08B
Enterprise Value	1.37B

Important Dates

The next estimated earnings date is Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	175.43M
Shares Outstanding	n/a
Shares Change (YoY)	+3.85%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	164.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.98
P/TBV Ratio	n/a
P/FCF Ratio	4.83
P/OCF Ratio	4.64
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 40.51, with an EV/FCF ratio of 6.15.

EV / Earnings	-1.75
EV / Sales	0.72
EV / EBITDA	40.51
EV / EBIT	n/a
EV / FCF	6.15

Financial Position

The company has a current ratio of 1.68, with a Debt / Equity ratio of 1.11.

Current Ratio	1.68
Quick Ratio	1.51
Debt / Equity	1.11
Debt / EBITDA	34.85
Debt / FCF	5.50
Interest Coverage	-7.80

Financial Efficiency

Return on equity (ROE) is -54.49% and return on invested capital (ROIC) is -3.38%.

Return on Equity (ROE)	-54.49%
Return on Assets (ROA)	-3.00%
Return on Invested Capital (ROIC)	-3.38%
Return on Capital Employed (ROCE)	-7.49%
Revenue Per Employee	390,484
Profits Per Employee	-154,854
Employee Count	5,500
Asset Turnover	0.66
Inventory Turnover	21.44

Taxes

Income Tax	-10.34M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.34% in the last 52 weeks. The beta is 1.10, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-10.34%
50-Day Moving Average	7.49
200-Day Moving Average	8.99
Relative Strength Index (RSI)	53.63
Average Volume (20 Days)	48,217

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.87

Income Statement

In the last 12 months, Teladoc Health had revenue of GBP 1.98 billion and -783.56 million in losses. Loss per share was -4.55.

Revenue	1.98B
Gross Profit	1.39B
Operating Income	-144.47M
Pretax Income	-793.90M
Net Income	-783.56M
EBITDA	25.40M
EBIT	-144.47M
Loss Per Share	-4.55

Full Income Statement

Balance Sheet

The company has 923.63 million in cash and 1.23 billion in debt, giving a net cash position of -304.52 million.

Cash & Cash Equivalents	923.63M
Total Debt	1.23B
Net Cash	-304.52M
Net Cash Per Share	n/a
Equity (Book Value)	1.10B
Book Value Per Share	6.30
Working Capital	502.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 232.72 million and capital expenditures -9.57 million, giving a free cash flow of 223.15 million.

Operating Cash Flow	232.72M
Capital Expenditures	-9.57M
Free Cash Flow	223.15M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.48%, with operating and profit margins of -7.31% and -39.66%.

Gross Margin	70.48%
Operating Margin	-7.31%
Pretax Margin	-40.18%
Profit Margin	-39.66%
EBITDA Margin	1.29%
EBIT Margin	-7.31%
FCF Margin	11.29%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.85%
Shareholder Yield	n/a
Earnings Yield	-72.63%
FCF Yield	20.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -5.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.33
Piotroski F-Score	4